#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	15062	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2114	707.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1415	1415	C	903	C,T	841,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	15062	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2114	707.2	0	HET	.	.	.	A198G	.	198	198	A	429	429	A	864	A,G	571,223	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27436	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3566	767.0	0	.	n	.	0	T695C	SNP	695	695	T	1021	1021	C	835	C	770	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27436	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3566	767.0	0	.	n	.	0	A1638G	SNP	1638	1638	A	1964	1964	G	949	G	882	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27436	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3566	767.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2297	2297	C	827	C,T	764,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27436	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3566	767.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2371	2371	A	864	A	814	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27436	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3566	767.0	1	SNP	n	C2597T	0	.	.	2597	2597	C	2923	2923	C	834	C,T	627,164	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	2104	folP	855	855	100.0	folP.l15.c4.ctg.1	1666	126.1	1	SNP	p	R229S	1	.	.	685	687	AGC	1171	1173	AGC	221;221;221	A;G;C	211;209;208	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4788	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3450	138.5	1	SNP	p	S91F	1	.	.	271	273	TTC	522	524	TTC	176;176;175	T;T;C,G	160;163;159,1	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4788	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3450	138.5	1	SNP	p	G95N	0	.	.	283	285	GGC	534	536	GGC	173;169;167	G;G;C	157;153;155	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4788	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3450	138.5	1	SNP	p	D95G	1	.	.	283	285	GGC	534	536	GGC	173;169;167	G;G;C	157;153;155	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	1634	mtrR	633	633	100.0	mtrR.l6.c30.ctg.1	1463	111.3	1	SNP	p	G45D	0	.	.	133	135	GGC	547	549	GGC	193;196;197	G;G;C	177;178;178	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	834	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c17.ctg.1	1051	78.5	0	.	n	.	0	A197.	DEL	197	197	A	496	496	A	172	A	157	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4836	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2984	161.5	1	SNP	p	D86N	0	.	.	256	258	GAC	568	570	GAC	216;215;218	G;A;C	199;195;205	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4836	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2984	161.5	1	SNP	p	R87W	0	.	.	259	261	CGT	571	573	CGT	217;217;218	C;G;T	203;201;200	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4836	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2984	161.5	1	SNP	p	R87I	0	.	.	259	261	CGT	571	573	CGT	217;217;218	C;G;T	203;201;200	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4836	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2984	161.5	1	SNP	p	S87R	1	.	.	259	261	CGT	571	573	CGT	217;217;218	C;G;T	203;201;200	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4836	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2984	161.5	1	SNP	p	S88P	0	.	.	262	264	TCC	574	576	TCC	218;219;220	T;C;C	202;200;201	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4226	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2676	157.1	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1590	1592	GGC	189;187;184	G;G,A;C,G	178;172,2;170,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	4124	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2561	160.8	1	SNP	p	A311V	0	.	.	931	933	GCC	1364	1366	GCC	226;227;226	G;C;C	214;213;213	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4124	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2561	160.8	1	SNP	p	I312M	1	.	.	934	936	ATG	1367	1369	ATG	225;226;228	A;T;G	213;214;214	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4124	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2561	160.8	1	SNP	p	T316P	0	.	.	946	948	ACC	1379	1381	ACC	228;228;226	A;C;C	213;216;213	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4124	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2561	160.8	1	SNP	p	V316T	1	.	.	946	948	ACC	1379	1381	ACC	228;228;226	A;C;C	213;216;213	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4124	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2561	160.8	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1880	1882	ACC	219;221;224	A;C,T;C	197;206,1;210	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4124	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2561	160.8	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1934	1936	GCG	207;204;207	G;C,A;G	193;189,1;192	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4124	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2561	160.8	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1934	1936	GCG	207;204;207	G;C,A;G	193;189,1;192	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4124	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2561	160.8	1	SNP	p	G542S	0	.	.	1624	1626	GGT	2057	2059	GGT	185;181;180	G;G;T	167;163;160	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4124	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2561	160.8	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2066	2068	AGC	171;170;172	A;G;C	156;157;156	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4124	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2561	160.8	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2084	2086	CCG	152;152;154	C,G;C;G	121,6;124;124	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5790	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3167	182.4	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1650	1652	CCG	194;197;199	C;C;G	170;177;177	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2192	porA	1146	1146	99.91	porA.l6.c4.ctg.1	1810	120.3	0	.	p	.	0	M83fs	FSHIFT	247	247	A	567	567	C	148	C	135	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2952	porB1b	1038	1038	99.9	porB1b.l15.c4.ctg.1	1502	194.6	1	SNP	p	G120K	1	.	.	358	360	AAG	610	612	AAG	240;237;238	A;A;G	226;225;221	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2952	porB1b	1038	1038	99.9	porB1b.l15.c4.ctg.1	1502	194.6	1	SNP	p	A121N	1	.	.	361	363	AAC	613	615	AAC	240;242;241	A;A;C	225;228;226	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2952	porB1b	1038	1038	99.9	porB1b.l15.c4.ctg.1	1502	194.6	1	SNP	p	N121D	0	.	.	361	363	AAC	613	615	AAC	240;242;241	A;A;C	225;228;226	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	326	porB3	990	356	90.14	porB3.l6.c30.ctg.2	648	25.5	0	.	p	.	0	S217G	NONSYN	649	651	AGC	98	100	GGC	15;15;15	G;G;C	15;15;15	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	326	porB3	990	356	90.14	porB3.l6.c30.ctg.2	648	25.5	0	.	p	.	0	D222N	NONSYN	664	666	GAT	113	115	AAT	16;16;16	A;A;T	16;16;16	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	326	porB3	990	356	90.14	porB3.l6.c30.ctg.2	648	25.5	0	.	p	.	0	V230A	NONSYN	688	690	GTA	137	139	GCA	18;18;18	G;C;A	17;18;18	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	326	porB3	990	356	90.14	porB3.l6.c30.ctg.2	648	25.5	0	.	p	.	0	V238Y	NONSYN	712	714	GTT	161	163	TAT	16;16;16	T;A;T	16;16;16	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	326	porB3	990	356	90.14	porB3.l6.c30.ctg.2	648	25.5	0	.	p	.	0	.	INDELS	715	717	GAA	165	171	GAGCAAT	16;16;16;16;17;17;17	G;A;G;C;A;A;T	16;16;16;16;17;17;17	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	326	porB3	990	356	90.14	porB3.l6.c30.ctg.2	648	25.5	0	.	p	.	0	.	INDELS	719	720	AC	174	176	GCG	23;23;27	G;C;G	21;21;24	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	326	porB3	990	356	90.14	porB3.l6.c30.ctg.2	648	25.5	0	.	p	.	0	L253V	NONSYN	757	759	TTG	215	217	GTA	37;37;36	G;T;A	34;34;34	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	326	porB3	990	356	90.14	porB3.l6.c30.ctg.2	648	25.5	0	.	p	.	0	S273T	NONSYN	817	819	TCG	275	277	ACT	59;55;55	A;C;T	52;50;48	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	326	porB3	990	356	90.14	porB3.l6.c30.ctg.2	648	25.5	0	.	p	.	0	K278N	NONSYN	832	834	AAA	290	292	AAC	44;46;48	A;A;C	41;43;43	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	326	porB3	990	356	90.14	porB3.l6.c30.ctg.2	648	25.5	0	.	p	.	0	R279H	NONSYN	835	837	CGC	293	295	CAC	49;49;51	C;A;C,G	45;45;46,1	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	326	porB3	990	356	90.14	porB3.l6.c30.ctg.2	648	25.5	0	.	p	.	0	E313A	NONSYN	937	939	GAA	395	397	GCA	37;36;34	G;C;A	31;30;30	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	326	porB3	990	356	90.14	porB3.l6.c30.ctg.2	648	25.5	0	.	p	.	0	N314D	NONSYN	940	942	AAC	398	400	GAC	32;30;29	G;A;C	29;27;27	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	326	porB3	990	356	90.14	porB3.l6.c30.ctg.2	648	25.5	0	.	p	.	0	F316I	NONSYN	946	948	TTC	404	406	ATC	27;26;25	A;T;C	26;24;24	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	326	porB3	990	356	90.14	porB3.l6.c30.ctg.2	648	25.5	0	.	p	.	0	A318S	NONSYN	952	954	GCG	410	412	TCG	18;19;20	T;C;G	18;18;19	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	326	porB3	990	356	90.14	porB3.l6.c30.ctg.2	648	25.5	0	.	p	.	0	G321S	NONSYN	961	963	GGC	419	421	AGC	19;19;19	A;G;C	16;17;17	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	326	porB3	990	356	90.14	porB3.l6.c30.ctg.2	648	25.5	0	.	p	.	0	G322A	NONSYN	964	966	GGT	422	424	GCC	20;20;20	G;C;C	18;18;18	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11060	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4919	224.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1170	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1040	111.6	1	SNP	p	V57M	1	.	.	169	171	ATG	524	526	ATG	229;228;229	A,G;T;G	215,1;217;219	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
